Diferencia entre revisiones de «Psilocybin toxicity»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
==Background == | ==Background== | ||
*A compound found in over 200 mushrooms that has mind altering properties similar to LSD. | *A compound found in over 200 mushrooms that has mind altering properties similar to LSD. | ||
*Commonly known as "magic mushrooms" or "shrooms". The mushroom are often taken recreationally for the euphoric and hallucinogenic effects. Typically grown in the Pacific Northwest and southern regions of the United States. | *Commonly known as "magic mushrooms" or "shrooms". The mushroom are often taken recreationally for the euphoric and hallucinogenic effects. Typically grown in the Pacific Northwest and southern regions of the United States. | ||
Revisión del 01:11 10 jul 2017
Background
- A compound found in over 200 mushrooms that has mind altering properties similar to LSD.
- Commonly known as "magic mushrooms" or "shrooms". The mushroom are often taken recreationally for the euphoric and hallucinogenic effects. Typically grown in the Pacific Northwest and southern regions of the United States.
- For a typical dose (1mg) symptoms will last 1-3 hours.
- Low toxicity with LD50 of 280mg/kg
- Therapeutic index = 641
Clinical Features
- Sensory/psychiatric
- Euphoria
- Visual hallucinations, synesthesia
- Lethargy, Depression
- Anxiety, agitation
- Confusion, disorientation
- Above may lead to accidental trauma
- Sympathetic effects
- Mydriasis
- Tachycardia
- Hypertension
- Nausea
- Hypotension
Differential Diagnosis
- Hypoglycemia
- TBI
- CO poisoning
- Meningitis/Encephalitis
- Opioid intoxication
- Antihistamines/Anticholinergic toxicity
Drugs of abuse
- 25C-NBOMe
- Alcohol
- Amphetamines
- Bath salts
- Cocaine
- Difluoroethane
- Ecstasy
- Gamma hydroxybutyrate (GHB)
- Heroin
- Inhalant abuse
- Hydrocarbon toxicity
- Difluoroethane (electronics duster)
- Marijuana
- Kratom
- Phencyclidine (PCP)
- Psilocybin ("magic mushrooms")
- Synthetic cannabinoids
- Chloral hydrate
- Body packing
Evaluation
- Clinical diagnosis
- Urine drug screen if concerned about co-ingestion
Management
- Supportive care
- Place patient in a calm and quiet environment
- Benzodiazepines for worsening tachycardia/hypertension or agitation
Disposition
- Discharge when vitals normalize and clinically sober